Earnings Projections

Search documents
Stay Ahead of the Game With CME (CME) Q2 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-07-18 14:15
Core Insights - CME Group is expected to report quarterly earnings of $2.90 per share, reflecting a 13.3% increase year-over-year, with revenues projected at $1.68 billion, a 9.4% increase from the previous year [1] Revenue Estimates - Analysts estimate 'Revenues- Other' to be $105.21 million, indicating a year-over-year decrease of 2.2% [4] - 'Revenues- Clearing and transaction fees' are expected to reach $1.37 billion, showing a year-over-year increase of 9.5% [4] - 'Revenues- Market data and information services' are projected at $195.23 million, representing an 11.6% increase from the prior year [4] - 'Revenues- Clearing and transaction fees- Interest rates' are forecasted at $451.83 million, a 15% increase year-over-year [5] - 'Revenues- Clearing and transaction fees- Foreign exchange' is expected to be $51.33 million, reflecting a 0.5% increase from the previous year [5] Volume Estimates - The consensus for 'Average daily volume (including NYMEX and COMEX)' is 29.65 million, up from 25.94 million year-over-year [6] - 'Average daily volume - Metals (including NYMEX and COMEX)' is projected at 901.03 thousand, compared to 868.00 thousand in the same quarter last year [6] - 'Average daily volume - Interest rates (including NYMEX and COMEX)' is expected to reach 15.15 million, up from 12.89 million year-over-year [7] - 'Average daily volume - Equity indexes (including NYMEX and COMEX)' is estimated at 7.62 million, compared to 6.78 million in the previous year [7] - 'Average daily volume - Foreign exchange (including NYMEX and COMEX)' is projected to remain at 1.08 million, unchanged from the previous year [8] - 'Average daily volume - Energy (including NYMEX and COMEX)' is expected to be 2.95 million, up from 2.45 million year-over-year [8] - 'Average daily volume - Agricultural commodities (including NYMEX and COMEX)' is forecasted at 1.95 million, compared to 1.88 million in the same quarter last year [9] Stock Performance - Over the past month, CME shares have returned +2.1%, while the Zacks S&P 500 composite has seen a +5.4% change, indicating that CME is likely to perform in line with the overall market [10]
Seeking Clues to Fiserv (FI) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
ZACKS· 2025-07-18 14:15
Core Insights - Analysts expect Fiserv (FI) to report quarterly earnings of $2.42 per share, reflecting a year-over-year increase of 13.6% [1] - Revenue projections for Fiserv stand at $5.2 billion, indicating an 8.5% increase from the same quarter last year [1] - There have been no revisions in the consensus EPS estimate over the last 30 days, suggesting stability in analysts' forecasts [1] Revenue Projections - The 'Revenue- Processing and services' is anticipated to reach $4.45 billion, representing a 7.6% increase from the prior-year quarter [4] - The 'Revenue- Product' is expected to be $1.06 billion, indicating a year-over-year change of 9.6% [4] - The 'Adjusted Revenue- Corporate and Other' is projected at $5.25 million, reflecting a 5% increase from the previous year [4] Stock Performance - Over the past month, Fiserv shares have returned +3.7%, compared to the Zacks S&P 500 composite's +5.4% [5] - Fiserv holds a Zacks Rank 3 (Hold), suggesting that its performance is likely to align with the overall market in the near term [5]
Gear Up for Philip Morris (PM) Q2 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-07-17 14:15
Core Viewpoint - Philip Morris is expected to report quarterly earnings of $1.85 per share, reflecting a 16.4% increase year-over-year, with revenues projected at $10.25 billion, an 8.3% increase from the previous year [1]. Earnings Projections - Analysts have revised the consensus EPS estimate 0.5% higher over the last 30 days, indicating a collective reevaluation of initial estimates [1][2]. Revenue Estimates - The estimated 'Net Revenues- Smoke-Free Excl. W&H- Total' is projected at $4.23 billion, showing a year-over-year change of +19.7% [4]. - 'Net Revenues- Combustible Tobacco- Total' is expected to reach $6.08 billion, indicating a +3.8% change from the prior-year quarter [4]. - 'Net Revenues by Geography- EA, AU & PMI DF' is forecasted at $1.77 billion, reflecting a +6.1% year-over-year change [5]. - 'Net Revenues by Geography- Europe' is anticipated to be $4.26 billion, with an +11.8% change from the previous year [5]. - 'Net Revenues by Geography- SSEA, CIS & MEA' is estimated at $2.93 billion, indicating a +5.9% change [5]. - 'Net Revenues by Geography- Americas' is projected to reach $1.33 billion, reflecting a +17.8% change from the prior-year quarter [6]. Shipment Volume Estimates - 'Shipment Volume - Cigarettes and HTUs - Total' is expected to be 195.25 billion, compared to 193.16 billion in the same quarter last year [6]. - 'Shipment Volume - EA, AU & PMI DF - Total' is projected at 27.10 billion, slightly down from 27.35 billion year-over-year [7]. - 'Shipment Volume - SSEA, CIS & MEA - Total' is expected to be 95.56 billion, compared to 94.33 billion in the same quarter last year [7]. - 'Shipment Volume - Americas - Total' is forecasted to reach 16.46 billion, up from 15.09 billion in the same quarter last year [8]. - 'Shipment Volume - Cigarettes and HTUs - Heated Tobacco Units' is projected at 38.37 billion, compared to 35.54 billion in the same quarter last year [8]. - 'Shipment Volume - Americas - Cigarettes' is expected to be 14.59 billion, slightly down from 14.89 billion year-over-year [9]. Market Performance - Philip Morris shares have shown a return of +0.4% over the past month, while the Zacks S&P 500 composite has changed by +4.2% [10].
Seeking Clues to CoStar (CSGP) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
ZACKS· 2025-07-17 14:15
Core Insights - CoStar Group (CSGP) is expected to report quarterly earnings of $0.14 per share, a decline of 6.7% year-over-year, with revenues forecasted at $771.67 million, reflecting a 13.8% increase compared to the same period last year [1] Earnings Estimates - The consensus EPS estimate for the quarter has not changed over the past 30 days, indicating that analysts have maintained their initial projections [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [3] Revenue Projections - The consensus estimate for CoStar's total revenues is $267.89 million, indicating a year-over-year change of +5.9% [5] - Analysts project 'Revenues- Information Services' to reach $36.74 million, reflecting a +10% change from the prior-year quarter [5] - 'Revenues- Other Marketplaces' are expected to be $50.20 million, showing a significant increase of +60.9% year-over-year [5] - 'Revenues- LoopNet' is forecasted at $74.65 million, indicating a +6.9% change [6] - 'Revenues- Residential' is expected to be $31.02 million, reflecting an +18.4% increase [6] - The average prediction for 'Revenues- Multifamily' stands at $293.26 million, indicating an +11% change from the prior-year quarter [6] Stock Performance - CoStar shares have increased by +7% in the past month, outperforming the Zacks S&P 500 composite, which has risen by +4.2% [6] - CoStar holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [6]
Seeking Clues to Comerica (CMA) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
ZACKS· 2025-07-15 14:16
Core Viewpoint - Comerica Incorporated (CMA) is expected to report a quarterly earnings per share (EPS) of $1.23, reflecting a decline of 19.6% year-over-year, while revenues are forecasted to increase by 2.5% to $844.72 million [1] Earnings Estimates - The consensus EPS estimate has been revised 1.3% lower in the last 30 days, indicating a reevaluation by analysts [2] - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3] Key Financial Metrics - The consensus estimate for the Efficiency Ratio is 70.1%, up from 67.8% in the same quarter last year [5] - Analysts project the Average Balance of Total earning assets to be $70.40 billion, down from $71.83 billion year-over-year [5] - Total nonperforming assets are expected to reach $306.34 million, compared to $226.00 million in the same quarter last year [6] - Total nonperforming loans are estimated at $308.51 million, also up from $226.00 million year-over-year [6] Income Projections - Net interest income is forecasted at $576.45 million, an increase from $533.00 million in the same quarter last year [7] - Total noninterest income is expected to be $263.45 million, down from $291.00 million year-over-year [7] - Service charges on deposit accounts are projected at $46.96 million, slightly up from $46.00 million last year [8] - Commercial lending fees are estimated at $16.82 million, down from $17.00 million in the same quarter last year [8] Additional Income Metrics - Fiduciary income is expected to be $54.69 million, down from $58.00 million year-over-year [9] - Letter of credit fees are projected at $11.94 million, up from $10.00 million last year [9] - Capital markets income is estimated at $32.83 million, down from $37.00 million in the same quarter last year [9] - Card fees are expected to reach $60.98 million, down from $64.00 million year-over-year [10] Stock Performance - Comerica shares have returned +15.1% over the past month, outperforming the Zacks S&P 500 composite's +5% change [11]
U.S. Bancorp (USB) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2025-07-14 14:16
Core Viewpoint - Analysts expect U.S. Bancorp (USB) to report quarterly earnings of $1.07 per share, reflecting a year-over-year increase of 9.2%, with revenues projected at $7.06 billion, up 3.3% from the previous year [1] Earnings Projections - The consensus EPS estimate has been revised down by 0.7% in the last 30 days, indicating a reassessment by analysts [1][2] Key Financial Metrics - Efficiency Ratio is forecasted to reach 59.1%, down from 61.0% in the same quarter last year [4] - Average Balances - Total earning assets are estimated at $611.20 billion, slightly up from $608.89 billion year-over-year [4] - Total nonperforming loans are projected at $1.72 billion, down from $1.81 billion in the same quarter last year [5] - Total nonperforming assets are expected to be $1.75 billion, compared to $1.85 billion a year ago [5] - Leverage ratio is anticipated to reach 8.5%, up from 8.1% year-over-year [6] - Tier 1 Capital Ratio is expected to be 12.5%, compared to 11.9% in the same quarter last year [6] - Total Noninterest Income is projected at $2.93 billion, up from $2.82 billion year-over-year [6] - Net interest income (taxable-equivalent basis) is likely to reach $4.12 billion, compared to $4.05 billion in the same quarter last year [7] - Mortgage banking revenue is expected at $179.55 million, down from $190.00 million year-over-year [7] - Other noninterest income is estimated at $157.21 million, slightly up from $157.00 million last year [8] - Commercial products revenue is projected at $391.02 million, compared to $374.00 million in the same quarter last year [8] - Service charges are expected to reach $322.07 million, compared to $322.00 million in the same quarter last year [9] Stock Performance - U.S. Bancorp shares have increased by 9.7% over the past month, outperforming the Zacks S&P 500 composite, which rose by 4% [10]
Exploring Analyst Estimates for Novartis (NVS) Q2 Earnings, Beyond Revenue and EPS
ZACKS· 2025-07-14 14:16
Core Viewpoint - Analysts project that Novartis will report quarterly earnings of $2.38 per share, reflecting a 20.8% year-over-year increase, with revenues expected to reach $14.04 billion, a 9% increase from the same quarter last year [1]. Revenue Estimates - Revenues from Solid Tumors for Tafinlar + Mekinist are estimated at $570.15 million, indicating a 9% increase year-over-year [4]. - Other revenues are projected to be $407.49 million, suggesting a 13.2% year-over-year increase [4]. - Revenues from Solid Tumors for Kisqali are expected to reach $1.09 billion, reflecting a significant 52.6% increase from the prior-year quarter [4]. - Hematology revenues from Promacta/Revolade are estimated at $545.35 million, showing a slight increase of 0.3% year-over-year [5]. - Hematology revenues from Tasigna in the US are projected at $221.75 million, indicating a decrease of 3.6% from the prior-year quarter [5]. - Revenues from Immunology for Cosentyx in the US are expected to be $993.18 million, reflecting a 14.4% year-over-year increase [6]. - Cardiovascular revenues from Entresto in the US are projected to reach $1.19 billion, indicating a 26% increase from the prior-year quarter [6]. - Revenues from Solid Tumors for Tafinlar + Mekinist in the ROW are estimated at $348.88 million, suggesting an 8.7% year-over-year increase [7]. - Immunology revenues for Cosentyx in the ROW are expected to be $740.74 million, reflecting a 12.6% year-over-year increase [8]. Stock Performance - Over the past month, Novartis shares have returned +1.3%, compared to a +4% change in the Zacks S&P 500 composite [8]. - Novartis currently holds a Zacks Rank 2 (Buy), indicating potential outperformance in the near future [8].
Insights Into Morgan Stanley (MS) Q2: Wall Street Projections for Key Metrics
ZACKS· 2025-07-11 14:16
Core Insights - Wall Street analysts expect Morgan Stanley to report quarterly earnings of $1.93 per share, reflecting a year-over-year increase of 6% [1] - Projected revenues are anticipated to be $15.92 billion, also up 6% from the previous year [1] - There has been a downward revision of 0.7% in the consensus EPS estimate over the last 30 days, indicating a reassessment by analysts [1][2] Revenue Projections - Analysts project 'Net revenues - Investment Management' to reach $1.52 billion, indicating a year-over-year change of +9.5% [4] - 'Net revenues - Institutional Securities' are forecasted to be $7.43 billion, reflecting a change of +6.5% from the prior-year quarter [4] - 'Revenues - Wealth Management - Net interest income' is expected to be $1.87 billion, suggesting a change of +4.2% year over year [4] Non-Interest Revenues and Book Value - Total non-interest revenues are predicted to reach $13.65 billion, indicating a year-over-year change of +5.4% [5] - The consensus estimate for 'Book value per common share' is projected at $60.90, compared to $56.80 from the previous year [5] - The estimate for 'Return on average common equity' stands at 13.1%, slightly up from 13.0% year over year [5] Assets Under Management - 'Wealth Management - Total client assets' is estimated at $5962.28 billion, up from $5690.00 billion in the same quarter last year [6] - 'Total assets under management' is expected to reach $1640.63 billion, compared to $1518.00 billion a year ago [6] - 'Assets under management - Liquidity and Overlay Services' is projected at $549.14 billion, up from $483.00 billion in the same quarter last year [7] Equity and Leverage Ratios - 'Assets under management - Equity' is expected to reach $310.77 billion, compared to $301.00 billion in the same quarter last year [8] - The estimated 'Tier 1 Leverage Ratio' is 6.8%, consistent with the previous year's figure [8] Stock Performance - Shares of Morgan Stanley have increased by +8.5% in the past month, outperforming the +4.1% move of the Zacks S&P 500 composite [9] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to mirror overall market performance in the near future [9]
Stay Ahead of the Game With South Plains Financial (SPFI) Q2 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-07-11 14:16
Core Viewpoint - South Plains Financial (SPFI) is expected to report quarterly earnings of $0.77 per share, a 16.7% increase year-over-year, with revenues projected at $51.7 million, reflecting a 6.4% growth compared to the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised 2.4% lower in the last 30 days, indicating a collective reevaluation by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Financial Metrics - The consensus estimate for the 'Efficiency ratio' is 64.7%, down from 66.7% a year ago [5]. - 'Nonperforming Loans' are expected to reach $7.70 million, a significant decrease from $23.45 million reported in the same quarter last year [5]. - 'Net Interest Margin (FTE)' is forecasted at 3.8%, up from 3.6% in the same quarter of the previous year [5]. - 'Average Balance - Total interest-earning assets' is estimated at $4.15 billion, compared to $4.00 billion reported last year [6]. - 'Net Interest Income' is projected at $39.59 million, an increase from $35.89 million reported in the same quarter last year [6][7]. - 'Total Noninterest Income' is expected to be $12.11 million, slightly down from $12.71 million a year ago [7]. Stock Performance - Over the past month, shares of South Plains Financial have returned +2.7%, while the Zacks S&P 500 composite has changed by +4.1% [7]. - Currently, SPFI holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the overall market in the near future [7].
Stay Ahead of the Game With M&T Bank (MTB) Q2 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-07-11 14:16
Core Viewpoint - Analysts project that M&T Bank Corporation (MTB) will report quarterly earnings of $4.03 per share, a 6.3% increase year over year, with revenues expected to reach $2.39 billion, up 3.6% from the same quarter last year [1]. Earnings Projections - The consensus EPS estimate has been revised down by 0.2% in the past 30 days, indicating a reassessment by covering analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Financial Metrics - Analysts forecast the 'Efficiency Ratio' to be 56.3%, compared to 55.3% a year ago [4]. - The 'Net Interest Margin' is expected to reach 3.7%, up from 3.6% in the same quarter last year [5]. - The 'Average Balance - Total Earning Assets' is projected at $191.73 billion, down from $193.68 billion year over year [5]. - The 'Tier 1 Leverage' is estimated at 10.1%, slightly up from 10.0% a year ago [5]. - The 'Tier 1 Capital Ratio' is expected to be 12.9%, down from 13.2% year over year [6]. - The 'Total Capital Ratio' is projected at 14.6%, compared to 14.9% a year ago [6]. - 'Total Other Income' is estimated at $638.93 million, up from $584.00 million year over year [6]. Revenue Estimates - The consensus for 'Net Interest Income - Taxable-Equivalent' stands at $1.76 billion, compared to $1.73 billion in the same quarter last year [7]. - 'Service Charges on Deposit Accounts' are estimated at $135.70 million, up from $127.00 million year over year [7]. - 'Trust Income' is projected to reach $181.34 million, compared to $170.00 million in the same quarter last year [8]. - 'Mortgage Banking Revenues' are expected to be $126.99 million, up from $106.00 million year over year [8]. - 'Net Interest Income' is anticipated to be $1.74 billion, compared to $1.72 billion a year ago [9]. Stock Performance - Over the past month, M&T Bank shares have returned +10.9%, outperforming the Zacks S&P 500 composite's +4.1% change [9].